Prevention, treatment and cure of HIV infection
- PMID: 37344551
- DOI: 10.1038/s41579-023-00914-1
Prevention, treatment and cure of HIV infection
Abstract
The development of antiretroviral therapy for the prevention and treatment of HIV infection has been marked by a series of remarkable successes. However, the efforts to develop a vaccine have largely failed, and efforts to discover a cure are only now beginning to gain traction. In this Review, we describe recent progress on all fronts - pre-exposure prophylaxis, vaccines, treatment and cure - and we discuss the unmet needs, both current and in the coming years. We describe the emerging arsenal of drugs, biologics and strategies that will hopefully address these needs. Although HIV research has largely been siloed in the past, this is changing, as the emerging research agenda is marked by multiple cross-discipline synergies and collaborations. As the limitations of antiretroviral drugs as a means to truly end the epidemic are becoming more apparent, there is a great need for continued efforts to develop an effective preventative vaccine and a scalable cure, both of which remain formidable challenges.
© 2023. Springer Nature Limited.
Similar articles
-
Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure.Annu Rev Med. 2016;67:215-28. doi: 10.1146/annurev-med-011514-023043. Epub 2015 Nov 2. Annu Rev Med. 2016. PMID: 26526767 Review.
-
Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies.Retrovirology. 2020 Apr 10;17(1):8. doi: 10.1186/s12977-020-00515-3. Retrovirology. 2020. PMID: 32276640 Free PMC article. Review.
-
Challenges in HIV Vaccine Research for Treatment and Prevention.Front Immunol. 2014 Sep 8;5:417. doi: 10.3389/fimmu.2014.00417. eCollection 2014. Front Immunol. 2014. PMID: 25250026 Free PMC article. Review.
-
HIV epidemiology, prevention, treatment, and implementation strategies for public health.Lancet. 2024 Feb 3;403(10425):471-492. doi: 10.1016/S0140-6736(23)01381-8. Epub 2023 Nov 30. Lancet. 2024. PMID: 38043552 Review.
-
CD8+ T cells in HIV control, cure and prevention.Nat Rev Immunol. 2020 Aug;20(8):471-482. doi: 10.1038/s41577-020-0274-9. Epub 2020 Feb 12. Nat Rev Immunol. 2020. PMID: 32051540 Free PMC article. Review.
Cited by
-
Cyclophilin inhibition as a strategy for the treatment of human disease.Front Pharmacol. 2024 Jul 8;15:1417945. doi: 10.3389/fphar.2024.1417945. eCollection 2024. Front Pharmacol. 2024. PMID: 39045055 Free PMC article. Review.
-
Biotech's role in advancing HIV vaccine development.Emerg Microbes Infect. 2024 Dec;13(1):2384460. doi: 10.1080/22221751.2024.2384460. Epub 2024 Aug 12. Emerg Microbes Infect. 2024. PMID: 39042015 Free PMC article.
-
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148. Vaccines (Basel). 2025. PMID: 40006695 Free PMC article. Review.
-
Combination immunotherapy induces post-intervention control of HIV.Res Sq [Preprint]. 2025 Mar 19:rs.3.rs-6141479. doi: 10.21203/rs.3.rs-6141479/v1. Res Sq. 2025. PMID: 40166020 Free PMC article. Preprint.
-
Phylogenetics and molecular evolution to understand and curb the HIV pandemic.Nat Rev Microbiol. 2025 Jun 30. doi: 10.1038/s41579-025-01202-w. Online ahead of print. Nat Rev Microbiol. 2025. PMID: 40588586 Review.
References
-
- Joint United Nations Programme on HIV/AIDS. Global HIV and AIDS statistics — 2022 fact sheet. UNAIDS https://www.unaids.org/en/resources/fact-sheet (2022).
-
- Cohen, S. E. et al. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV https://doi.org/10.1016/S2352-3018(18)30288-1 (2018). - DOI - PubMed - PMC
-
- Cohen, S. M., Hu, X., Sweeney, P., Johnson, A. S. & Hall, H. I. HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. J. Acquir. Immune Defic. Syndr. 67, 519–527 (2014). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous